Dmg Group, LLC Liquidia Corp Transaction History
Dmg Group, LLC
- $121 Million
- Q1 2025
A detailed history of Dmg Group, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Dmg Group, LLC holds 16,881 shares of LQDA stock, worth $265,369. This represents 0.21% of its overall portfolio holdings.
Number of Shares
16,881
Previous 16,302
3.55%
Holding current value
$265,369
Previous $191,000
29.84%
% of portfolio
0.21%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding LQDA
# of Institutions
188Shares Held
44.6MCall Options Held
1.22MPut Options Held
1.09M-
Black Rock Inc. New York, NY4.24MShares$66.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$55.9 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$51.7 Million0.21% of portfolio
-
Findell Capital Management LLC New York, NY3.08MShares$48.4 Million14.82% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$35.6 Million1.69% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.01B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...